Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Leukapheresis Market Analysis, Trends & Forecasts (2019-2025) - ResearchAndMarkets.com

November 29, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 29, 2019--

The “Leukapheresis - Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

The Leukapheresis market worldwide is projected to grow by US$12.1 Million, driven by a compounded growth of 7.1%.

Leukapheresis Devices, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$14.4 Million by the year 2025, Leukapheresis Devices will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 8.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$557.4 Thousand to the region’s size and clout in the next 5 to 6 years. Over US$566.1 Thousand worth of projected demand in the region will come from the rest of the European markets.

In Japan, Leukapheresis Devices will reach a market size of US$1.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.8% over the next couple of years and add approximately US$2.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.

All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:

  • Allcells LLC
  • Asahi Kasei Medical Co. Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC
  • MacoPharma S.A.
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/54dsa0

View source version on businesswire.com:https://www.businesswire.com/news/home/20191129005353/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/29/2019 01:20 PM/DISC: 11/29/2019 01:20 PM